Versican proteolysis predicts immune effector infiltration and post-transplant survival in myeloma

被引：14
|
作者：
Dhakal, Binod [1 ]
Pagenkopf, Adam [2 ,3 ]
Mushtaq, Muhammad Umair [2 ,3 ]
Cunningham, Ashley M. [4 ]
Flietner, Evan [2 ,3 ]
Morrow, Zachary [2 ,3 ]
Papadas, Athanasios [2 ,3 ]
Hope, Chelsea [2 ,3 ]
Leith, Catherine [5 ]
Hematti, Peiman [2 ,3 ]
Hari, Parameswaran [1 ]
Callander, Natalie S. [2 ,3 ]
Asimakopoulos, Fotis [2 ,3 ]
机构：
[1] Med Coll Wisconsin, Dept Med, Div Hematol Oncol, Milwaukee, WI 53226 USA
[2] Univ Wisconsin Madison, Dept Med, Div Hematol Oncol, Madison, WI USA
[3] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA
[4] Med Coll Wisconsin, Div Pathol & Lab Med, Milwaukee, WI 53226 USA
[5] Univ Wisconsin Madison, Div Pathol & Lab Med, Madison, WI USA
来源：
LEUKEMIA & LYMPHOMA | 2019年 / 60卷 / 10期
关键词：
MULTIPLE-MYELOMA; ROLES;
D O I：
10.1080/10428194.2019.1585836
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2558 / 2562
页数：5
相关论文
共 50 条
  • [1] Versican (VCAN) Proteolysis Predicts T-Cell Infiltration in Myeloma Bone Marrow Post- Autologous Stem Cell Transplant (ASCT)
    Pagenkopf, Adam
    Dhakal, Binod
    Hope, Chelsea L.
    Papadas, Athanasios
    Johnson, Michael G.
    Nagel, Bradley
    Kurudza, Elena
    Partha, Samik
    Ruffolo, Bianca
    Leith, Catherine
    Miyamoto, Shigeki
    Hematti, Peiman
    Hari, Parameswaran
    Callander, Natalie Scott
    Asimakopoulos, Fotios
    BLOOD, 2017, 130
  • [2] Pre-Heart Transplant Spirometry Predicts Post-Transplant Survival
    Lundgren, S.
    Lowes, B.
    Lyden, E.
    Zolty, R.
    Hyden, M.
    Burdorf, A.
    Um, J. Y.
    Stoller, D.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S280 - S280
  • [3] Versican proteolysis signature as a potential immune infiltration biomarker for colorectal cancer
    Buckalew, Derek
    Kraus, Sean
    Johnson, Katie
    Pasch, Cheri A.
    Deming, Dustin A.
    CANCER RESEARCH, 2024, 84 (06)
  • [4] Pre-transplant mortality risk predicts post-transplant survival in pediatric liver transplant recipients
    Mogul, Douglas
    Luo, Xun
    Massie, Allan
    Chow, Eric
    Schwarz, Kathleen B.
    Cameron, Andrew M.
    Bridges, John F.
    Segev, Dorry L.
    HEPATOLOGY, 2015, 62 : 1050A - 1050A
  • [5] Investigating the role of post-transplant bone marrow immune dysregulation in multiple myeloma
    Wang, Julia T.
    Fiala, Mark
    Sato, Kazuhito
    Fortier, Julie
    Vij, Ravi
    Ding, Li
    CANCER RESEARCH, 2024, 84 (06)
  • [6] An immune function assay predicts post-transplant recurrence in patients with hepatocellular carcinoma
    Cheng, Jian-Wen
    Shi, Ying-Hong
    Fan, Jia
    Huang, Xiao-Wu
    Qiu, Shuang-Jian
    Xiao, Yong-Sheng
    Wang, Zheng
    Dai, Zhi
    Tang, Zhao-You
    Zhou, Jian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (10) : 1445 - 1453
  • [7] Stem cell contamination predicts post-transplant survival in AL amyloidosis.
    Comenzo, RL
    Wally, J
    Kica, G
    Skinner, M
    Zhang, Y
    BLOOD, 1999, 94 (10) : 575A - 575A
  • [8] An immune function assay predicts post-transplant recurrence in patients with hepatocellular carcinoma
    Jian-Wen Cheng
    Ying-Hong Shi
    Jia Fan
    Xiao-Wu Huang
    Shuang-Jian Qiu
    Yong-Sheng Xiao
    Zheng Wang
    Zhi Dai
    Zhao-You Tang
    Jian Zhou
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1445 - 1453
  • [9] MELD as a Predictor of Post-Transplant Survival
    Luo, Xun
    Massie, Allan
    King, Elizabeth
    Ahmed, Rizwan
    Poon, Anna
    Segev, Dorry
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 : 90 - 91
  • [10] MELD as a Predictor of Post-Transplant Survival
    Luo, X.
    Massie, A.
    Poon, A.
    Segev, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
12345